Table 5.
AXL immunohistochemical expression compared with clinicopathologic variables for patients with triple-negative tumours
| Characteristic (n=128) | Number | Axl H-Score median (min, max) | p Value |
|---|---|---|---|
| Age (mean years±SD) | 56±14.3 | ||
| Stage | 0.175 | ||
| I | 65 | 15 (0, 285) | |
| II | 54 | 35 (0, 300) | |
| III | 9 | 60 (0, 300) | |
| Tumour size | 0.997 | ||
| T1 | 84 | 15 (0, 300) | |
| T2 | 41 | 30 (0, 300) | |
| T3 | 3 | 60 (30, 80) | |
| Node status | 0.011 | ||
| N0 | 96 | 20 (0, 285) | |
| N1 | 23 | 80 (0, 300) | |
| N2 | 4 | 137.5 (10, 300) | |
| N3 | 5 | 10 (0, 140) | |
| Histologic grade | 0.784 | ||
| 1 | 2 | 40 (0, 80) | |
| 2 | 17 | 10 (0, 210) | |
| 3 | 107 | 20 (0, 300) | |
| ILC | 2 | 120 (0, 240) | |
| Lymphovascular invasion | 0.026 | ||
| Present | 30 | 40 (0, 270) | |
| Absent | 98 | 17.5 (0, 300) |
ILC, invasive lobular carcinoma.